WEED, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
April 01, 2024 at 04:40 pm EDT
Share
WEED, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported net loss was USD 0.031557 million compared to USD 1.53 million a year ago. Basic loss per share from continuing operations was USD 0.0003 compared to USD 0.013 a year ago.
WEED, Inc. is engaged in the business involving the purchase of land and building commercial grade cultivation centers to consult, assist, manage and lease to licensed dispensary owners and organic grow operators on a contract basis, with a concentration on the legal and medical marijuana sector. The Company and its subsidiaries are focused on various business opportunities in the cannabis and hemp field, including, but not limited to both indoor and outdoor grows, cultivations and harvest for research, product development, processing and manufacturing of both Pharma and non-Pharma products, services, therapeutics, and treatments on a global basis for both the medical cannabis and hemp global market space. The Company, through its subsidiary, Sangre AT, LLC, doing business as Sangre AgroTech, is engaged in genomic sequencing, genetics-based breeding, plant tissue culture, and plant biochemistry. Its other subsidiaries include WEED Israel Cannabis Ltd, WEED Australia Ltd, and others.
WEED, INC. 